ABOUT US
Cannadol Pharmaceuticals Ltd. is a public Australian company that will manufacture and market three cannabis-based products in Australia: Cannadol, Cannapax and Cannadeine.
Cannadol is a unique, terpenoid blend in a hemp plant and seed oil base. However, we prefer to call it a cell food.
This is because it nourishes the endocannabinoid system to maintain homeostasis within the body, keeping all systems in balance.
The terpenes have anti-inflammatory and anti-anxiety effects, and the direct action on the CB2 receptors in the body induces analgesia, assisting with modulating pain.
Cannadol is a 30mL bottle, taken sub-lingually through a dropper (under the tongue), and will be available for over-the-counter sale in pharmacies.
Registered Trademark IP Right Number 1863987.
Cannapax contains a unique blend of essential oils in a hempseed oil base, peppermint oil and natural sweetener (960).
It is a source of Omega 3, 6, 9 and is suitable for vegans and vegetarians.
Cannapax is a 30mL bottle, taken sub-lingually through a dropper (under the tongue), and will be available for over-the-counter sale in pharmacies.
Cannadeine is a compound which contains Delta 9-THC in a range that the body uses most efficiently.
According to our patent, the unique ratio of Delta 9-THC, additional cannabinoids and terpenes, provides the ideal synergy to effectively address pain and anxiety.
Cannadeine is taken orally and will be prescribed by doctors.
Cannadeine will undergo trialling, overseen by Southern Star Research to comply with Therapeutic Goods Administration regulations.
Patent application registration No. 2019901486.